Complete DARE Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
DARE Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 7 peer companies in Healthcare
P/E Ratio
$-11.88
-464.5%
Peer Median: 62.1x
EV/EBITDA
$0.00
-100.0%
Peer Median: 45.3x
P/S Ratio
$16.40
+403.0%
Peer Median: 14.8x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for DARE's business model and current situation.
Multiple Comparison
| Multiple | DARE Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -17.0x | 62.1x | 62.1x | -127.4% | Undervalued |
| EV/EBITDA | Infinityx | 45.3x | 45.3x | Infinity% | Overvalued |
| P/S Ratio | 2.9x | 14.8x | 12.3x | -80.1% | Undervalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.03B | 0.0x | 0.0x | 14.6x | |
| $0.03B | 0.0x | 0.0x | 16.9x | |
| $0.03B | 0.0x | 0.0x | 0.0x | |
| $0.03B | 0.0x | 0.0x | 2.9x | |
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.03B | 0.0x | 0.0x | 0.0x | |
| $725.66B | 62.1x | 45.3x | 14.8x |